The study followed approximately 35,000 coronary heart diseases patients in a Veterans Affairs network over 11 months.
Of the approximately 30,000 heart disease patients with safe LDL levels recorded at a recent visit, one-third were retested unnecessarily for cholesterol levels during an 11-month follow-up period.
Study authors suggest that improving cholesterol medication guidelines for those with coronary heart disease to a dose-based approach rather than a treat-to-target-level approach could greatly reduce the number of redundant tests performed.
More Articles on Quality:
FirstHealth Moore Regional Taken Off Immediate Jeopardy Status
Quality Improvement and Infection Reduction Make Financial Sense, Study Says
Poor Communication Leads to Unsafe Discharges to Skilled Nursing Facilities, Study Finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
